J. MARTIN CARROLL - 01 Jun 2022 Form 3 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig
Issuer symbol
ESPR
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
3
Filing time
01 Jun 2022, 16:20:43 UTC
Previous filing
01 Dec 2021
Next filing
03 Jun 2022

No securities are beneficially owned.